Globus Medical (GMED) Net Cash Flow (2011 - 2026)

Globus Medical (GMED) has 16 years of Net Cash Flow data on file, last reported at $37.9 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 111.6% year-over-year to $37.9 million; the trailing twelve-month figure through Mar 2026 stood at $83.9 million (down 16.21% YoY), and the FY2025 full-year result was -$280.7 million, down 188.59% from the prior year.
• Net Cash Flow for Q1 2026 stood at $37.9 million, down from $150.4 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $208.3 million in Q3 2024 and bottomed at -$326.7 million in Q1 2025.
• The 5-year median for Net Cash Flow is $37.9 million (2026), against an average of $20.4 million.
• The widest annual swing landed in 2023, when Net Cash Flow soared 1000.68%; it then plunged 568.12% in 2025.
• A 5-year view of Net Cash Flow shows it stood at $17.1 million in 2022, then jumped by 1000.68% to $188.0 million in 2023, then dropped by 11.74% to $166.0 million in 2024, then declined by 9.4% to $150.4 million in 2025, then slumped by 74.8% to $37.9 million in 2026.
• The last three Net Cash Flow figures came in at $37.9 million (Q1 2026), $150.4 million (Q4 2025), and $141.8 million (Q3 2025), per Business Quant data.

Peer Comparison